ROBERT W. ROSS - 15 Jun 2022 Form 4 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield , Attorney-in-Fact
Issuer symbol
XLO
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 16:08:24 UTC
Previous filing
03 Mar 2022
Next filing
05 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XLO Stock Option (right to buy) Award $0 +26,400 $0.000000 26,400 15 Jun 2022 Common Stock 26,400 $2.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was granted on June 15, 2022 and will vest in three equal installments on June 15, 2023, June 15, 2024 and June 15, 2025.